{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:46:22Z","timestamp":1791755182617,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long-term exposure to anticholinergic and sedative drugs could be a modifiable risk factor for cognitive decline. The objective of this study was to measure the association between previous cumulative anticholinergic and sedative drug exposure (Drug Burden Index) and cognitive decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cohort study (MEMORA cohort) was conducted in a French memory clinic for patients attending a consultation between November 2014 and December 2020, with at least 2 Mini-Mental State Examination (MMSE) measurements (\u2265\u20096\u00a0months apart) and available medication data from the local Primary Health Insurance Fund database (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,970). Drug Burden Index was linearly cumulated until each MMSE measurement and was used to categorise patients according to their level of exposure (no exposure, moderate, or high). The longitudinal association between Drug Burden Index and MMSE was assessed using a multivariate linear mixed model, adjusted for age, education level, anxiety disorders, depressive disorders, functional autonomy, and behavioural disorders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 1,970 patients were included with a mean follow-up duration of 2.78\u00a0years (\u00b1\u20091.54) and 2.99 visits per patients (5,900 MMSE\u2009+\u2009Drug Burden Index measurements collected). At baseline, 68.0% of patients had moderate cumulative anticholinergic and sedative drug exposure and a mean MMSE of 21.1. MMSE decrease was steeper in patients with moderate and high Drug Burden Index ( -1.74 and -1.70\/year, respectively) than in patients with no exposure (-1.26\/year) after adjusting for age, education, anxiety and depressive disorders, functional autonomy, and behavioural disorders (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Long-term exposure to anticholinergic and sedative drugs is associated with steeper cognitive decline. Medication review focusing on de-prescribing these drugs could be implemented early to reduce cognitive impairment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01530-8","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:01:34Z","timestamp":1721692894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults: a memory clinic cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Elsa","family":"Reallon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Moutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Dauphinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Desnavailles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy","family":"Novais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Krolak-Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Garnier-Crussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Mouchoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MEMORA group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Makaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dautricourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Danaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Waissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Sarciron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Guilhermet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Gaujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Grosma\u00eetre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vernaudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Desestret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Grang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Teillac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Verdurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Delphin-Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Bathsavanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Bachelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Nour","family":"Temedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"1530_CR1","unstructured":"National Institute on Aging. Alzheimer\u2019s Disease Fact Sheet. https:\/\/www.nia.nih.gov\/health\/alzheimers-disease-fact-sheet. Accessed 23 mai 2022."},{"issue":"1","key":"1530_CR2","first-page":"7","volume":"18","author":"Z Aajami","year":"2019","unstructured":"Aajami Z, Kebriaeezadeh A, Nikfar S. Direct and indirect cost of managing Alzheimer\u2019s disease in the Islamic Republic of Iran. Iran J Neurol. 2019;18(1):7\u201312.","journal-title":"Iran J Neurol"},{"issue":"1","key":"1530_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1532-5415.2007.01499.x","volume":"56","author":"K P\u00e9r\u00e8s","year":"2008","unstructured":"P\u00e9r\u00e8s K, Helmer C, Amieva H, Orgogozo JM, Rouch I, Dartigues JF, et al. Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc. 2008;56(1):37\u201344.","journal-title":"J Am Geriatr Soc"},{"key":"1530_CR4","first-page":"225","volume":"4","author":"N Campbell","year":"2009","unstructured":"Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225\u201333.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"1530_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","volume":"15","author":"AR Moore","year":"1999","unstructured":"Moore AR, O\u2019Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15\u201328.","journal-title":"Drugs Aging"},{"issue":"1","key":"1530_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jamda.2020.04.019","volume":"22","author":"A Egberts","year":"2021","unstructured":"Egberts A, Moreno-Gonzalez R, Alan H, Ziere G, Mattace-Raso FUS. Anticholinergic drug burden and delirium: a systematic review. J Am Med Dir Assoc. 2021;22(1):65\u201373.e4.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"1530_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ageing\/afaa090","volume":"49","author":"NT Pieper","year":"2020","unstructured":"Pieper NT, Grossi CM, Chan WY, Loke YK, Savva GM, Haroulis C, et al. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis. Age Ageing. 2020;49(6):939\u201347.","journal-title":"Age Ageing"},{"key":"1530_CR8","first-page":"CD013540","volume":"5","author":"M Taylor-Rowan","year":"2021","unstructured":"Taylor-Rowan M, Edwards S, Noel-Storr AH, McCleery J, Myint PK, Soiza R, et al. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database Syst Rev. 2021;5:CD013540.","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"1530_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bcp.13734","volume":"85","author":"L Andre","year":"2019","unstructured":"Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, et al. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study. Br J Clin Pharmacol. 2019;85(1):71\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1530_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/07853890.2016.1252053","volume":"49","author":"KM Jamsen","year":"2017","unstructured":"Jamsen KM, Gnjidic D, Hilmer SN, Ilom\u00e4ki J, Le Couteur DG, Blyth FM, et al. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study. Ann Med. 2017;49(2):157\u201364.","journal-title":"Ann Med"},{"issue":"3","key":"1530_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40266-019-00735-z","volume":"37","author":"K Cardwell","year":"2020","unstructured":"Cardwell K, Kerse N, Ryan C, Teh R, Moyes SA, Menzies O, et al. The Association Between Drug Burden Index (DBI) and Health-Related Outcomes: A Longitudinal Study of the \u00ab\u202fOldest Old\u202f\u00bb (LiLACS NZ). Drugs Aging. 2020;37(3):205\u201313.","journal-title":"Drugs Aging"},{"issue":"1","key":"1530_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11096-020-01117-x","volume":"43","author":"M Lavrador","year":"2021","unstructured":"Lavrador M, Cabral AC, Figueiredo IV, Ver\u00edssimo MT, Castel-Branco MM, Fernandez-Llimos F. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. Int J Clin Pharm. 2021;43(1):128\u201336.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1530_CR13","first-page":"357","volume":"75","author":"H Wouters","year":"2020","unstructured":"Wouters H, Hilmer SN, Gnjidic D, Van Campen JP, Teichert M, Van Der Meer HG, et al. Long-Term Exposure to Anticholinergic and Sedative Medications and Cognitive and Physical Function in Later Life. J Gerontol A Biol Sci Med Sci. 2020;75(2):357\u201365.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1530_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jgs.12632","volume":"62","author":"M Kashyap","year":"2014","unstructured":"Kashyap M, Belleville S, Mulsant BH, Hilmer SN, Paquette A, Tu LM, et al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc. 2014;62(2):336\u201341.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"1530_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40266-015-0310-9","volume":"32","author":"K Cardwell","year":"2015","unstructured":"Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the \u2018Oldest Old\u2019: a systematic review of the literature. Drugs Aging. 2015;32(10):835\u201348.","journal-title":"Drugs Aging"},{"issue":"1","key":"1530_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12877-019-1204-1","volume":"19","author":"V Dauphinot","year":"2019","unstructured":"Dauphinot V, Moutet C, Rouch I, Verdurand M, Mouchoux C, Delphin-Combe F, et al. A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol. BMC Geriatr. 2019;19(1):191.","journal-title":"BMC Geriatr"},{"issue":"9596","key":"1530_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"8","key":"1530_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781\u20137.","journal-title":"Arch Intern Med"},{"key":"1530_CR19","unstructured":"WHO. Defined Daily Dose (DDD). https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd. Accessed 11 Apr 2022"},{"issue":"7","key":"1530_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/jgs.12343","volume":"61","author":"R Faure","year":"2013","unstructured":"Faure R, Dauphinot V, Krolak-Salmon P, Mouchoux C. A standard international version of the Drug Burden Index for cross-national comparison of the functional burden of medications in older people. J Am Geriatr Soc. 2013;61(7):1227\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"1530_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Dur\u00e1n","year":"2013","unstructured":"Dur\u00e1n CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485\u201396.","journal-title":"Eur J Clin Pharmacol"},{"key":"1530_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31.","journal-title":"BMC Geriatr"},{"issue":"3","key":"1530_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res."},{"issue":"3","key":"1530_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179\u201386.","journal-title":"Gerontologist"},{"issue":"11","key":"1530_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(05)70219-2","volume":"4","author":"I McKeith","year":"2005","unstructured":"McKeith I, Cummings J. Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurol. 2005;4(11):735\u201342.","journal-title":"Lancet Neurol"},{"key":"1530_CR26","unstructured":"R Foundation for Statistical Computing. R Development Core Team (2010). R: A language and environment for statistical computing. 2010. http:\/\/www.R-project.org. Accessed 8 Feb 2022."},{"issue":"12","key":"1530_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/gps.1811","volume":"22","author":"EJM Bierman","year":"2007","unstructured":"Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry. 2007;22(12):1194\u2013200.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"3","key":"1530_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/sj.clpt.6100303","volume":"83","author":"YJ Cao","year":"2008","unstructured":"Cao YJ, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83(3):422\u20139.","journal-title":"Clin Pharmacol Ther."},{"issue":"2","key":"1530_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","volume":"59","author":"N Lechevallier-Michel","year":"2005","unstructured":"Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-R\u00e9glat A. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005;59(2):143\u201351.","journal-title":"Br J Clin Pharmacol."},{"issue":"9","key":"1530_CR30","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/01.wnl.0000183152.16690.26","volume":"65","author":"RD Nebes","year":"2005","unstructured":"Nebes RD, Pollock BG, Meltzer CC, Saxton JA, Houck PR, Halligan EM, et al. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology. 2005;65(9):1487\u20139.","journal-title":"Neurology."},{"issue":"3","key":"1530_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40266-013-0055-2","volume":"30","author":"J Uusvaara","year":"2013","unstructured":"Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE. Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study. Drugs Aging. 2013;30(3):177\u201382.","journal-title":"Drugs Aging."},{"issue":"7","key":"1530_CR32","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.3390\/ijerph20075322","volume":"20","author":"M Espaulella-Ferrer","year":"2023","unstructured":"Espaulella-Ferrer M, Molist-Brunet N, Espaulella-Panicot J, Sevilla-S\u00e1nchez D, Puigoriol-Juvanteny E, Otero-Vi\u00f1as M. Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study. Int J Environ Res Public Health. 2023;20(7):5322.","journal-title":"Int J Environ Res Public Health."},{"key":"1530_CR33","doi-asserted-by":"publisher","first-page":"1136757","DOI":"10.3389\/fphar.2023.1136757","volume":"14","author":"B Katzenberger","year":"2023","unstructured":"Katzenberger B, Koller D, Strobl R, Kisch R, Sanftenberg L, Voigt K, et al. Exposure to anticholinergic and sedative medication is associated with impaired functioning in older people with vertigo, dizziness and balance disorders-Results from the longitudinal multicenter study MobilE-TRA. Front Pharmacol. 2023;14:1136757.","journal-title":"Front Pharmacol."},{"issue":"2","key":"1530_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/0091270010395591","volume":"52","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. 2012;52(2):258\u201365.","journal-title":"J Clin Pharmacol."},{"issue":"7539","key":"1530_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"ML Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332(7539):455\u20139.","journal-title":"BMJ."},{"issue":"6","key":"1530_CR36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/ageing\/afr102","volume":"40","author":"C Fox","year":"2011","unstructured":"Fox C, Livingston G, Maidment ID, Coulton S, Smithard DG, Boustani M, et al. The impact of anticholinergic burden in Alzheimer\u2019s dementia-the LASER-AD study. Age Ageing. 2011;40(6):730\u20135.","journal-title":"Age Ageing."},{"issue":"2","key":"1530_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-2012-110935","volume":"30","author":"LJ Whalley","year":"2012","unstructured":"Whalley LJ, Sharma S, Fox HC, Murray AD, Staff RT, Duthie AC, et al. Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia. J Alzheimers Dis. 2012;30(2):253\u201361.","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"1530_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1530_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing."},{"issue":"7","key":"1530_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.revmed.2008.08.010","volume":"30","author":"ML Laroche","year":"2009","unstructured":"Laroche ML, Bouthier F, Merle L, Charmes JP. Potentially inappropriate medications in the elderly: a list adapted to French medical practice. Rev Med Interne. 2009;30(7):592\u2013601.","journal-title":"Rev Med Interne."},{"issue":"7","key":"1530_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","volume":"71","author":"A Renom-Guiteras","year":"2015","unstructured":"Renom-Guiteras A, Meyer G, Th\u00fcrmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861\u201375.","journal-title":"Eur J Clin Pharmacol."},{"issue":"11","key":"1530_CR42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00228-021-03145-6","volume":"77","author":"B Roux","year":"2021","unstructured":"Roux B, Berthou-Contreras J, Beuscart JB, Charenton-Blavignac M, Doucet J, Fournier JP, et al. REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria. Eur J Clin Pharmacol. 2021;77(11):1713\u201324.","journal-title":"Eur J Clin Pharmacol."},{"key":"1530_CR43","doi-asserted-by":"publisher","first-page":"105021","DOI":"10.1016\/j.jamda.2024.105021","volume":"2024","author":"BM Liu","year":"2024","unstructured":"Liu BM, Redston MR, Fujita K, Thillainadesan J, Gnjidic D, Hilmer SN. The impact of deprescribing interventions on the drug burden index and other outcomes: a systematic review. J Am Med Dir Assoc. 2024;2024:105021\u20135.","journal-title":"J Am Med Dir Assoc."},{"issue":"9","key":"1530_CR44","doi-asserted-by":"publisher","first-page":"afad176","DOI":"10.1093\/ageing\/afad176","volume":"52","author":"E Braithwaite","year":"2023","unstructured":"Braithwaite E, Todd OM, Atkin A, Hulatt R, Tadrous R, Alldred DP, et al. Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis. Age Ageing. 2023;52(9):afad176.","journal-title":"Age Ageing."},{"issue":"10","key":"1530_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.neurol.2022.06.012","volume":"178","author":"N Villain","year":"2022","unstructured":"Villain N, Planche V, Levy R. High-clearance anti-amyloid immunotherapies in Alzheimer\u2019s disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects. Rev Neurol (Paris). 2022;178(10):1011\u201330.","journal-title":"Rev Neurol (Paris)."}],"updated-by":[{"DOI":"10.1186\/s13195-024-01560-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01530-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01530-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01530-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T03:03:01Z","timestamp":1724986981000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01530-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01530-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-024-01560-2","URL":"https:\/\/doi.org\/10.1186\/s13195-024-01560-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MEMORA cohort obtained agreements from the local ethics committee on July 29, 2014 (<i>Comit\u00e9 de Protection des Personnes Sud Est III<\/i>). Authorisation for handling personal data was granted by the national data protection authority. As the MEMORA cohort was classified as a research conducted in current practice and was not associated with risks or constraints for participants, information was individually provided to patients and caregivers at inclusion, and they had the right to refuse their participation in the research and withdraw their participation at any point. The MEMORA cohort is registered on ClinicalTrials.gov (NCT02302482).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}